Browse by author
Lookup NU author(s): Dr Joanna Elson, Dr Ilse Pienaar
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2017 Springer Science+Business Media, LLC, part of Springer Nature Parkinson’s disease (PD) is conventionally seen as resulting from single-system neurodegeneration affecting nigrostriatal dopaminergic neurons. However, accumulating evidence indicates multi-system degeneration and neurotransmitter deficiencies, including cholinergic neurons which degenerate in a brainstem nucleus, the pedunculopontine nucleus (PPN), resulting in motor and cognitive impairments. The neuropeptide galanin can inhibit cholinergic transmission, while being upregulated in degenerating brain regions associated with cognitive decline. Here we determined the temporal-spatial profile of progressive expression of endogenous galanin within degenerating cholinergic neurons, across the rostro-caudal axis of the PPN, by utilizing the lactacystin-induced rat model of PD. First, we show progressive neuronal death affecting nigral dopaminergic and PPN cholinergic neurons, reflecting that seen in PD patients, to facilitate use of this model for assessing the therapeutic potential of bioactive peptides. Next, stereological analyses of the lesioned brain hemisphere found that the number of PPN cholinergic neurons expressing galanin increased by 11%, compared to sham-lesioned controls, and increasing by a further 5% as the neurodegenerative process evolved. Galanin upregulation within cholinergic PPN neurons was most prevalent closest to the intra-nigral lesion site, suggesting that galanin upregulation in such neurons adapt intrinsically to neurodegeneration, to possibly neuroprotect. This is the first report on the extent and pattern of galanin expression in cholinergic neurons across distinct PPN subregions in both the intact rat CNS and lactacystin-lesioned rats. The findings pave the way for future work to target galanin signaling in the PPN, to determine the extent to which upregulated galanin expression could offer a viable treatment strategy for ameliorating PD symptoms associated with cholinergic degeneration.
Author(s): Elson JL, Kochaj R, Reynolds R, Pienaar IS
Publication type: Article
Publication status: Published
Journal: Neurotoxicity Research
Year: 2018
Volume: 34
Issue: 1
Pages: 16-31
Print publication date: 01/07/2018
Online publication date: 07/12/2017
Acceptance date: 22/11/2017
ISSN (print): 1029-8428
ISSN (electronic): 1476-3524
Publisher: Springer
URL: https://doi.org/10.1007/s12640-017-9846-2
DOI: 10.1007/s12640-017-9846-2
Altmetrics provided by Altmetric
